|
|
|
American Medical Systems Holdings, Inc. (NasdaqGS: AMMD - News) reported strong fiscal third quarter results. Margins American Medical Systems reported strong growth in margins on the basis of higher sales and tight...
Theragenics Corporation (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the third quarter ended October 4, 2009....
Everything you wanted to know about Infertility Infertility implies the failure to conceive. So a coitus to be capable of fertilisation, must take place within twelve hours of ovulation (release of ovum from the ovary). The...
This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this...
CHICAGO (MedPage Today) -- Prostate cancer patients had a reduced risk of biochemical failure if they were taking a statin during during radiation therapy, data from a retrospective cohort study showed.
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe...
blobssek bij pl/topic_195/ ] [IMG]70 86 110 130/meme/st/thumbs/037/1750789932 jpg [/IMG] blobssek bij pl/topic_190/ ] [IMG]70 86 110 130/meme/st/thumbs/050/5021127034 jpg [/IMG] blobssek bij pl/topic_184/ ] [IMG]70 86 110...
The European Men's Health Forum (EMHF) launches new website enabling men across Europe and the world to ask questions anonymously online about their prostates and have them answered promptly and in the detail they need by a...
Enlargement of the prostate gland is one of the most frequent diseases in men over 50. Nearly all men are affected by an enlargement of the prostate but the magnitude and rate of progression varies. In other cases, the...
Published: Nov. 5, 2009 at 1:38 AM COLUMBUS, Ohio, Nov. 5 (UPI) -- Blood vessel type may predict how aggressively a prostate tumor will proceed, U.S. researchers said. The study, published in the Journal of Clinical Oncology,...
